Emerging biomarkers in inflammatory bowel disease (embark) study identifies fecal calprotectin, serum mmp9, and serum il-22 as a novel combination of biomarkers for crohn's disease activity: Role of cross-sectional imaging

William A. Faubion, Joel G. Fletcher, Sharon O'Byrne, Brian G. Feagan, Willem Js De Villiers, Bruce Salzberg, Scott Plevy, Deborah D. Proctor, John F. Valentine, Peter D. Higgins, Jeffrey M. Harris, Lauri Diehl, Lilyan Wright, Gaik Wei Tew, Diana Luca, Karen Basu, Mary E. Keir

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Emerging biomarkers in inflammatory bowel disease (embark) study identifies fecal calprotectin, serum mmp9, and serum il-22 as a novel combination of biomarkers for crohn's disease activity: Role of cross-sectional imaging'. Together they form a unique fingerprint.

Medicine & Life Sciences